Dave A. Miller

Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA.

WiSpry, Inc. manufactures RF-CMOS integrated circuits and components. It offers tunable RF components, digital capacitor arrays, RF evaluation kits, filters and duplexors, and power amplifiers. The firm's products are used in airbag sensors, game controllers, accelerometers, microoptics, video projection systems, and printer heads. It serves mobile handset manufacturers and network operators. The company was founded by Jeffrey L. Hilbert and Arthur S. Morris III in October 2002 and is headquartered in Irvine, CA.

House Party, Inc. organizes house parties and events. It puts brands into the hands, homes and conversations of consumer brand advocates through its member-based community, proprietary digital platform, and in home events. The company was founded by Gene DeRose and Parker Reilly in 2005 and is headquartered in Irvington, NY.

DeepDyve, Inc. provides online rental services for scholarly and professional research articles. It offers articles on subject areas, such as business and finance, computer science, humanities, life sciences, medicine, patents and law and social sciences. The company was founded by Tom Tang and Qianjin Hu in 2005 and is headquartered in Redwood, CA.

Gluware, Inc. offers cloud-based network automation services. It automates the configuration and management of complex deployments. The firm's products include Gluware, Gluware control, Gluware lab and Gluware platform. The company was founded by Jeff Gray and Olivier Huynh Van in 2007 and is headquartered in Sacramento, CA.

Tube, Inc. engages in the design, development and production of prepackaged computer software. The firm develops and operates network-aware mobile marketing platform that enables advertisers, businesses, and service vendors to increase visibility around their products and services on mobile sites and applications, while funding end users' mobile data consumption. The company was founded by Harjot Saluja and Mung Chiang and is headquartered in Chelmsford, MA.

RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona.

DPT Laboratories Ltd. develops and manufactures pharmaceutical products. It offers full-service outsourcing solutions including pharmaceutical development, site transfers and state-of-the-art pharmaceutical manufacturing, packaging and distribution services. The company was founded by John W. Feik in 1938 and is headquartered in San Antonio, TX.

Greylock Management Corp (Greylock Partners) is a venture capital firm founded in 1965 by Charlie P. Waite and Daniel S. Gregory. The firm is headquartered in Menlo Park, California.

Imagine Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops small molecules that enable the delivery of cancer therapeutics to meta-static and primary brain tumors. The company is headquartered in San Diego, CA.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015.

Therapeutic Human Polyclonals, Inc. develops human antibody therapeutics. Its technology will enable the generation of monoclonal and polyclonal antibody therapeutics. The company is headquartered in Mountain View, CA.

DREAM Charter Schools is a community-focused organization that provides a welcoming and nurturing environment for children. The non-profit company is based in New York, NY. The CEOs of DREAM Charter Schools are Eve Colavito and Richard A. Berlin. The company, founded in 1991, aims to create schools where children are known, seen, and loved.

Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022.

CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA.

Sertoli Technologies, Inc. provides medical services. It develops products to treat insulin-dependent diabetes and hemophilia. The company technology enables treatment of life-threatening diseases caused by a patient's impaired ability to produce a protein, such as insulin in diabetes or factor XIII in hemophilia. Sertoli Technologies was founded in 1996 and is headquartered in Tucson, AZ.

Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA.

La Jolla Playhouse, Inc. provides educational opportunities for children, teens, and adults interested in theatre arts. The company was founded by Gregory Peck, Dorothy McGuire, and Mel Ferrer in 1947 and is headquartered in La Jolla, CA.

IntegriCo Composites, Inc. manufactures and markets composite plastic products made from recycled plastic. It offers composite and wood railroad ties, and wood core ties. The firm's technology mixes landfill-bound plastics to create composite railroad ties and other related products which are used in petrochemical, creosote, termite damage and grade crossing applications. The company was founded by Gershon Yaniv and J. Michael Miller in 2007 and is headquartered in Sarepta, LA.

Flinn Foundation engages as a philanthropic grantmaking organization. It helps in the advancement of the state's bioscience sector and provides education to high-achieving students at an Arizona public university. The company was founded by Robert S. Finn and Irene Flinn in 1965 and is headquartered in Phoenix, AZ.

Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA.

Research Corporation Technologies, Inc. provides investment related services. It operates as technology development company that typically invests in new technology platforms in life sciences, healthcare technology, biomedical, preclinical and clinical-stage therapeutics, devices, drugs, and diagnostics, medical devices, and biotech tools for gene expression and protein production with medical devices. The company was founded in 1987 and is headquartered in Tucson, AZ.

Part of Dhanuka Laboratories Ltd., Orchid Pharma, Inc. is a company that manufactures and sells pharmaceutical ingredients and finished dosage forms. The company is based in Princeton, NJ.

BioIVT LLC engages in the provision of research models and value-added research services for drug discovery and development. It offers biofluids, cell products, and molecular products. The company is headquartered in Wilmington, DE.

Formulated Solutions LLC innovates, formulates, creates and co-markets consumer brands. It focus on consumer healthcare, over-the-counter (OTC), medical device, and prescription drug production. The firm also develops custom packaging to suit product needs. The company was founded by Eric Dann on October 11, 2000 and is headquartered in Largo, FL.

Reterro, Inc. provides soil remediation and waste-stream cleaning services. The firm provides a mobile and compliant solution for hydrocarbon contamination cleanup. The company was founded in 2013 and is headquartered in Livermore, CA.

DTx Pharma, Inc. engages in the provision of biotechnology solutions. It focuses on the utilization of fatty acids to enable the delivery of RNA therapeutics to tissues and organ systems beyond the liver. The company was founded by Arthur T. Suckow, John Grundy, and Adam Pavlicek in August 2017 and is headquartered in San Diego, CA.

Selkirk Pharma, Inc. engages in the supply of drug products. It offers aseptic fill and finish, laboratory, project management, and regulatory support services. The company was founded in 2017 and is headquartered in Spokane, WA.

TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation.

Pheon Therapeutics Ltd. is an antibody drug conjugate (ADC) specialist that develops a pipeline of monotherapies for novel targets and/or with novel payloads. The company is based in Harpdenden, UK. The British company's lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types. ADCs offer the potential to treat solid tumors and liquid cancers that have not responded to other treatments. The company was founded in 2015 by Paul Jackson. Cyrus D. Mozayeni has been the CEO of the company since 2023.